Owkin assinou um novo acordo de vários anos com a AstraZeneca centrado em torno do K Pro, plataforma de IA agente da Owkin projetada para pesquisa farmacêutica e tomada de decisões estratégicas. Sob o ...
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results